Fig. 2From: The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injuryHeMoVal study assessment flowchart: Graphical representation of the different phases of assessment (enrollment, baseline assessment, monitoring, 3-months follow-up), measurements and analysis in the HeMoVal studyBack to article page